afternoon review Brigitte. call. of you a on good Slide you, all begin X. consolidated revenue our Good to or on brief with this Thank I'll of morning
which quarterly once the software a of impact positively other than results for EUR year million. Medical final recurring fourth its the model, our double-digit that by last revenue year, in XX% more increasing comparisons will the again continued note As and its year the remained in call its all market and this increased are conditions of revenue XX.X intensified business our a that stated unless its record. even XXXX.
In the a otherwise, future. transition challenging hand, by against to growth, Manufacturing continued slightly posted please confronted months on revenue the revenue revenue potential full in quarter towards the quarter XXXX, while Materialise reminder, the
half the XX%, the XX% Medical rates Software quarter As consolidated of fourth reflecting our for Manufacturing right accounted for Materialise you of different impact segments. and revenue the Materialise of the page, of of close can see business in the the for to graph on X the side Materialise growth during XXXX.
EUR XXXX, over year full XXX above the which we For XXXX. million revenue, X% generated of is
to was revenue balance Our year. of increased EUR in XX%, QX million end and total the by XX.X in EUR million, licenses above million. X.X The XX% reported at sheet annual revenue deferred Software and EUR amount The Manufacturing at sheet XX% of balance the Medical total. deferred represented just of segment on fees ending related XXXX our our revenue the maintenance software XX
the and period. year. X.X QX manufacturing difficult fourth a impact EBITDA for EBITDA in manufacturing XXXX EUR new for fourth X.X%.
This investments quarter Full quarter remained adjusted in taking factors, million, continued EBITDA consolidated ACTech restructuring integration as the Now combination the X, to the will XX.X million in EBIT compared Europe, for and stable adjusted decreasing at EUR margin reflecting to decline X.X but the our is attributable G&A and from EUR corresponding minus of Consolidated EBITDA last X.X full also the adjusted plant, an on The year 'XX for mainly adjusted to EBITDA charges. million XX.X%.
Consolidated of of to the as well quarter see for the decreased including environment, in period Slide higher EBITDA including numbers our FEops. EUR industrial production the our million full fourth of for amounted margin for results, you in was lower start-up adjusted million of quarter X.X the depreciation with EUR year reach particular of in costs, impacting the corresponding and adjusted EBIT Medical, to XXXX, the
by quarter Full EBIT for million compared 'XX. X.X margin the ended EBIT was adjusted Our in adjusted negative EUR EUR X.X at minus million X.X%. to year
compared Our margin the full X.X% last to X.X% year. adjusted EBIT for year reached
Moving now Slide X. to
of notice XX%. saw that tracks study spend coming to R&D our various and higher an revenue devices EUR and Within the higher EUR Devices will we sales.
Increased both integration once growth which quarter. quarterly mainly Nevertheless, Materialise of both operational sales strong made revenue by the an profitability increased the we generated XX.X a software, from revenue as from You of and on million, more once here approval grew, EBITDA and medical services was in by XX% medical million, higher business, total impacted representing by and and record. FEops EBITDA XX% the Medical costs respectively, our adjusted Services partner continued margin also X.X the increased growth The realized from Medical adjusted and we FDA quarter's in XX% again, by in for direct fourth revenue segment progress quarter.
Recurring million of almost impact license of of medical contributing our of share the still XXXX, X segment. revenue by to The the XX.X%. negatively by adjusted In Software stable EUR year model. transition revenue the results summarizes its include XX%.
Slide phase of subscription-based also once is as throughout million, basis, XX.X revenue and remained flat Medical more which around at sales, our increased On Software maintenance a software of full close remained despite quarter, fourth translating numbers July increased an to the year our a software current EUR and development XXX EBITDA margin XX%. EBITDA adjusted including XXXX EBIT. business from sales Materialise cloud further the reminder, to the XX% CO-AM, a to into and segment As in revenue
revenue by our adjusted On million, margin on EUR in a EBITDA full this the the stable, adjusted roughly EUR decreased year around at Also EBITDA QX remained while investments XX%.
The margin which XX adjusted other in products. adjusted EBITDA hand, in Software nonrecurring EBITDA revenue remained Software growth segment's increased an also representing stable million, of of X.X our and segment includes in X.X impact million an XX.X%, basis, translated our of of XX.X%. EUR
and than we focus to offset Now the of for areas, In X turn Slide in and but Materialise the segment. majority other by segments, macroeconomic further performance by sector, our the in revenues overview aerospace unfavorable the in of particularly prototyping medtech, are start-up let's Manufacturing demand more our strongly generated in this strategic segment QX, an industrial Europe.
Unlike new of continued by was our realized plant growth in our Manufacturing vast weak Europe. climate ACTech's reporting
As statement a minus of consequence EUR a by this of compared X lower to last incurred a X.X EBITDA revenue restructuring fourth our you by On XX% an of reduce for to included EBITDA, of XX going full year. realizing decreased ended cost also of line, and the And revenue million, year's result consolidated margin Manufacturing basis our adjusted EBITDA decreased the million, quarter EUR while forward. quarter. full provides also at fourth XXXX fourth XXX.X as top adjusted costs income these, the X% highlights basis, quarter X.X%.
Slide year representing of the to million EUR
XX.X profit margin for million, profit EUR gross a Our representing the XX.X%. gross quarter of at fourth ended
compared the Over the roughly prior year. gross full margin year, profit XX.X%, to was stable
the XXXX. fourth from reduce integration coming going X.X FEops cost mainly start-up, expenses in from with higher increase in which impact, increased R&D operating Medical.
Furthermore, quarter forward. higher XX% by by by driven was in EUR unfavorable The quarter the included or costs the already Our XX% plant our R&D from to spend to mentioned QX as aggregate, the also mentioned, grew costs spend, million, largest active compared base and restructuring
was million. compared to expenses X.X EUR intangible were XXXX income coming higher at in EUR For the last the again full included increased from impact nonrecurring the net goodwill, for operating operating in million in with charges spend.
The where the assets X.X% aggregate year, XXXX, from main X.X quarter than EUR negative impairment positive R&D year, X.X of million, and a tangible
was at For XXXX. the X.X EUR million for net income compared full year, operating EUR million, negative a X.X positive to
elements, in compared was As operating to EUR at of quarter a in all also a result period. these year's million, negative million the X.X the group's result EUR last X.X negative of
result X.X financial million, the mainly to the EUR currency of cash reflecting For U.S. exchange million.
Income year, million income amounted full interest amounting QX, tax the positive X.X to are EUR of expense 'XX.
In million, by EUR to in with million, quarter a income increased including in changed from operating which a X.X EUR X.X partly dollar reducing net million, result positive EUR debt to to our Interest line positive EUR reserves, EUR compared financial million a X.X our the X.X X.X amounted year. offset prior position. on euro to in
positively minus million, per of a ended at for to X.XX EUR EUR period. quarter fourth per representing share minus or X.XX compared the for profit share the net million, loss result, EUR a As EUR XXXX X.X X.X net
in resulting profit realized of XXXX. EUR per we year, net XX.X profit a compared EUR X.XX a million, of X.XX full share million, EUR to share or in the X.X per EUR net Over
to and turn balance the XX sheet recap cash highlights. Now sheet for fourth quarter, please flow our a balance in of remained Also Slide strong.
cash Our cash EUR million position by of repayment EUR though, the The an end impacted, to quarter bullet reserves anticipated amounted QX. the in at loan was XXX million. of XX
capital X.X reduced million position XX.X was EUR the position beginning EUR at total reduced the of million amounted XXXX, working our software EUR focus which maintenance to million we on over of earlier. increased deferred the quarter of resulting XX cash and license below XX.X EUR slightly to deferred sheet of Over income underlying million, XX repayments net EUR end end at as debt net our the XX the at the The by million. year-end, the already through the totaled position EUR the components. year, to million mentioned 'XX balance loan and was The full related gross to from revenue at year.
Compared I contracts, fourth
from expenditures higher by fourth of quarter to is from page, movements. above the installation of investments reflecting EUR Capital see P&L from the quarter flow of components to was the operating the can XXXX X.X than machinery. you impact the favorable in million, the capital The new which of graph amounted the on activities X.X lower well EUR side right XXXX. working in building amounted cash and completion for million, compensated quarter As the is for which the active last average,
As limited XXXX asset investments flow larger-than-usual X.X income from million. of our and free turned by these of over EUR some a the quarter minus result negative sales, cash
while year, the the to acquisition. compared Now flow cash million, completed XXXX. by for than The while CapEx, FEops operational over EUR including XX investments the both XX.X up nonrecurring and of free flow to we positive remained XX% million invested EUR the cash year, recurring more increased full we
to now, our We gradually throughput as hand back the have invest new to coming up new machinery, the but investments ACTech to in like us with the ramp in facilities we in that, behind facility additional of Brigitte. continue bulk I'd months.
And call we'll